Vivos Therapeutics (VVOS)
0.19
+0.02 (11.76%)
Upcoming Events
Latest Headlines
Vivos Therapeutics to Present at the 2026 Moody Capital Solutions Disruptive Growth & Life Sciences Conference
September 1, 2026 8:02 AM - StreetInsider
New to The Street Broadcasting Today at 6:30 PM EST on Bloomberg Television Across the U.S., Latin America and MENA-Featuring FreeCast (NASDAQ: CAST), Metaterra Holdings (MTHI) and SafeSpace Global (S
August 29, 2026 9:23 AM - StreetInsider
Vivos Therapeutics signs deal for Florida sleep center with cardiologists
August 28, 2026 8:45 AM - StreetInsider
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
August 28, 2026 8:45 AM - StreetInsider
Form 4 Vivos Therapeutics, Inc. For: Jul 31 Filed by: Amman Bradford K.
August 26, 2026 4:10 PM - SEC Filing
Vivos Therapeutics reports 212% rise in Nevada patient referrals
August 25, 2026 8:45 AM - StreetInsider
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
August 25, 2026 8:45 AM - Globe NewsWire
Vivos Therapeutics Reports Record New Patient Referrals at its Nevada Sleep & Airway Medicine Centers
August 25, 2026 8:45 AM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Aug 20
August 21, 2026 5:30 PM - SEC Filing
Vivos Therapeutics opens sleep center in Henderson, Nevada
August 20, 2026 10:24 AM - StreetInsider
Vivos Therapeutics Opens New Sleep Testing and Treatment Facility in Nevada to Meet Rapidly Growing Patient Demand for Sleep Apnea Testing and Treatment
August 20, 2026 10:24 AM - Globe NewsWire
Vivos Therapeutics (VVOS) Tops Q2 EPS by 6c
August 17, 2026 6:16 AM - StreetInsider
Vivos Therapeutics posts 35% revenue gain but widens net loss
August 14, 2026 4:29 PM - StreetInsider
Vivos Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Update
August 14, 2026 4:29 PM - Globe NewsWire
Form 10-Q Vivos Therapeutics, Inc. For: Jun 30
August 14, 2026 4:13 PM - SEC Filing
Form SCHEDULE 13G/A Vivos Therapeutics, Inc. Filed by: ARMISTICE CAPITAL, LLC
August 14, 2026 10:30 AM - SEC Filing
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
August 14, 2026 8:45 AM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Aug 05
August 11, 2026 5:03 PM - SEC Filing
Form SCHEDULE 13G Vivos Therapeutics, Inc. Filed by: Streeterville Capital LLC
August 11, 2026 1:28 PM - SEC Filing
Vivos Therapeutics expands AI platform deal with Greenway Health
August 11, 2026 8:49 AM - StreetInsider
Vivos Therapeutics Expands Greenway Health Partnership to Deploy AI-Enabled Platform Across All Clinical and Revenue Operations
August 11, 2026 8:45 AM - StreetInsider
Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology
August 5, 2026 8:30 AM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Jul 31
August 3, 2026 5:29 PM - SEC Filing
Form SCHEDULE 13D Vivos Therapeutics, Inc. Filed by: V-Co Investors 4 LLC
July 15, 2026 5:07 PM - SEC Filing
Form 4 Vivos Therapeutics, Inc. For: Jun 30 Filed by: Skaff Michael C
July 15, 2026 4:24 PM - SEC Filing
Form 3 Vivos Therapeutics, Inc. For: Jun 30 Filed by: V-Co Investors 4 LLC
July 15, 2026 4:22 PM - SEC Filing
Form 8-K Vivos Therapeutics, Inc. For: Jul 07
July 7, 2026 5:30 PM - SEC Filing
Vivos reports insomnia improvement in small Vida appliance study
June 30, 2026 8:46 AM - StreetInsider
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
June 30, 2026 8:45 AM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Jun 25
June 25, 2026 5:22 PM - SEC Filing
Vivos Therapeutics extends Streeterville debt conversion deal to August
June 22, 2026 8:30 AM - StreetInsider
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
June 22, 2026 8:30 AM - StreetInsider
Form 8-K Vivos Therapeutics, Inc. For: Jun 16
June 16, 2026 5:03 PM - SEC Filing
Form 8-K Vivos Therapeutics, Inc. For: Jun 15
June 16, 2026 6:02 AM - SEC Filing
Vivos Therapeutics plans rights offering to raise capital
June 11, 2026 8:30 AM - StreetInsider
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
June 11, 2026 8:30 AM - StreetInsider
Vivos partners with Florida cardiology group for sleep disorder treatment
June 10, 2026 9:04 AM - StreetInsider
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
June 10, 2026 9:03 AM - Globe NewsWire
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
June 8, 2026 1:40 PM - StreetInsider
Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026
June 8, 2026 1:39 PM - Globe NewsWire
Form 8-K Vivos Therapeutics, Inc. For: Jun 08
June 8, 2026 8:30 AM - SEC Filing
Full Article List
